Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Changes in Quality of Life following Buprenorphine Treatment

Relationship with Treatment Retention and Illicit Opioid Use

Dados Bibliográficos

ID13913275
AutoresShannon Gwin Mitchell (0000-0002-2841-1085, Friends Research Institute, autor correspondente), Jan Gryczynski (0000-0001-5920-4057, Friends Research Institute), Robert P Schwartz (0000-0002-4707-5726, Friends Research Institute), C Patrick Myers, Kevin E O’Grady (0000-0001-6565-7802, University of Maryland, College Park), Yngvild K Olsen, Yngvild Olsen (Realistic Education in Action Coalition to Foster Health), Jerome H Jaffe (Friends Research Institute)
Ano2015
Volume47
Fascículo2
Páginas149-157
Data de publicação2015-03-15
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoJournal of Psychoactive Drugs (JOURNAL)
Identificadores do periódicoISSN: 0279-1072 • E-ISSN: 2159-9777
EditoraTaylor & Francis (PUBLISHER • GB)
DOI10.1080/02791072.2015.1014948
PMID25950595
PMCIDPMC4425232
OpenAlexW2117016228
IdiomaEN
Citações recebidas3
Referências citadas39

Studies of substance abuse treatment outcomes that give priority to cessation of all drug use may obscure other tangible benefits of treatment that are important to patients. The aim of this study was to examine the association between changes in quality of life (QoL) and: (1) retention in treatment; and (2) opioid use as measured by self-report and urine testing. Participants were 300 African American men and women starting outpatient buprenorphine treatment. Participants completed assessments at baseline, three and six months consisting of the World Health Organization's Quality of Life brief scale, Addiction Severity Index, and urine testing for opioids. There were statistically significant increases over time across all four QoL domains: physical, psychological, environmental, and social. Self-reported frequency of opioid use was negatively associated with psychological QoL, but opioid urine test results were not significantly associated with any QoL domains. Continued treatment enrollment was significantly associated with higher psychological QoL and environmental QoL. Patients entering buprenorphine treatment experience improvements in QoL, which are amplified for patients who remain in treatment. Point-prevalence opiate urine test results obtained at each assessment were not associated with any of the QoL domains and may not accurately reflect improvements perceived by patients receiving buprenorphine treatment

Addiction · Buprenorphine · Methadone · Opiate · Opioid · Opioid use disorder · Psychiatry · Quality of life (healthcare · Substance abuse · Urine · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Internal Medicine

  • Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States

    Stephanie K Rubel, Matthew Eisenstat et al.•Substance Use & Misuse•2023

  • Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative

    Open Access•Thomas Patton, Jan R Böhnke et al.•Quality of Life Research•2024

  • Rethinking retention in treatment of opioid dependence—The eye of the beholder

    Open Access•Marc Vogel, Kenneth M Dürsteler et al.•International Journal of Drug…•2017

  • Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Richard P Mattick, Courtney Breen et al.•Cochrane Database of Systematic…•2014

  • Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

    Richard P Mattick, Courtney Breen et al.•Cochrane Database of Systematic…•2009

  • The fifth edition of the addiction severity index

    Open Access•A Thomas McLellan, Harvey W Kushner et al.•Journal of Substance Abuse…•1992

  • Measurement of health status

    Open Access•Roman Jaeschke, Joel Singer et al.•Controlled Clinical Trials•1989

  • Depression and Quality of Life in Older Persons

    Open Access•Heidi Sivertsen, Guro Hanevold Bjørkløf et al.•Dementia and Geriatric Cognitive…•2015

  • HIV prevention among drug users

    Carl A Latkin, Carl Latkin et al.•Health Psychology•2003

  • The World Health Organization's WHOQOL-BREF quality of life assessment

    Open Access•Suzanne M Skevington, Mohamed Lotfy et al.•Quality of Life Research•2004

  • A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation

    Open Access•Ronan E O'Carroll, K Smith et al.•Quality of Life Research•2000

  • Health-related quality of life changes associated with buprenorphine treatment for opioid dependence

    Open Access•Dennis W Raisch, Heather Campbell et al.•Quality of Life Research•2011

  • Quality of life in the Danish general population – normative data and validity of WHOQOL-BREF using Rasch and item response theory models

    Open Access•Vibeke Noerholm, M Groenvold et al.•Quality of Life Research•2004

  • Interpreting the WHOQOL-Brèf

    Open Access•Graeme Hawthorne, Helen Herrman et al.•Social Indicators Research•2006

Obras citantes distintas3
Citações por ano0,33
Intervalo de citações2017 - 2024 (8)
Velocidade de citaçãorecent
Altamente citadoNão
Tipos de citaçãoNeutras: 3
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae